Avicanna (TSE:AVCN) has released an update.
Avicanna Inc., an international biopharmaceutical company, has successfully paid off its $1,445,000 debt previously owed under the August 2023 Debentures. The company is known for its focus on developing and commercializing cannabinoid-based products across various medical and pharmaceutical segments.
For further insights into TSE:AVCN stock, check out TipRanks’ Stock Analysis page.
